🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury

RecruitingNAAges 18 Years - anyAllMindmaze SA
NCT05728840 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Stroke is the leading cause of long-term disability with an increasing incidence, especially in young adults. Among the cognitive difficulties following brain damage, deficits in attention are frequent and pervasive, affecting between 46% and 92% of stroke survivors. The current project targets patients with acquired brain injury, including stroke, traumatic brain injury, and brain tumor. The main objective of this study is to evaluate the use and the efficacy of a training program targeting attention and executive function difficulties, using gamified and digitized versions in virtual reality of standard cognitive exercises for patients with brain lesions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Time from stroke onset \< 1 month * Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation * Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan) * Able to give informed consent as documented by signature * Age \>= 18 years old Exclusion Criteria: * Epilepsy * Inability or contraindications to undergo the investigated intervention * Major psychiatric co-morbidity * Major neurocognitive deficits (e.g. dementia) * Incapacity to discriminate colors * General cognitive state preventing to understand and perform the tasks * Decision to not be informed of incidental findings
💊

What it tests

  • Immersive virtual reality gamified cognitive activities
  • Double neuropsychological standard activities
📍

Where

1 site
University of Lausanne Hospitals
Lausanne, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy